Additionally, Zhang et al. demonstrated that suppression of USP17 inhibits NSCLC tumorigenesis and growth by targeting matrix metallopeptidase 3 (MMP3) and MMP9 [48]. Here, USP17L2 is linked to non-small cell lung carcinoma.